All Articles tagged EQ-5D

• Other Conditions
  February 19, 2025 EDT
  A Vignette Study to Derive Health-Related Quality-of-Life Weights for Individuals with Steroid Refractory Chronic Graft-versus-Host Disease Receiving Third-Line Therapy in the United Kingdom
  Emma WilliamsLuke SkinnerRichard HudsonArunesh SilKatharina EcsyElisheva LewAbdul Jabbar Omar AlsalehElin GruffyddAndrew LloydDaniele Avenoso

  This non-interventional health-related quality of life study involved the development, validation, and valuation of health state vignettes to generate utility values for chronic graft-versus-host disease in the UK.

  Abstract
• Genetic Disorders
  September 18, 2024 EDT
  Health-Related Quality-of-Life Utility Values in Adults With Late-Onset Pompe Disease: Analyses of EQ-5D Data From the PROPEL Clinical Trial
  Alison GriffithsSimon ShohetNeil JohnsonAlasdair MacCulloch

  This analysis of EQ-5D health-related quality-of-life utility data from the PROPEL clinical trial compared cipaglucosidase alfa plus miglustat vs alglucosidase alfa plus placebo in late-onset Pompe disease.

  Abstract
• Genetic Disorders
  March 03, 2023 EDT
  Quality of Life with Late-Onset Pompe Disease: Qualitative Interviews and General Public Utility Estimation in the United Kingdom
  Lena HubigAnna-Katrine SussexAlasdair MacCullochDerralynn HughesRyan GrahamLiz MorrisSyed RazaAndrew J. LloydAmanda SowinskiKaty Gallop

  This study aimed to develop health state vignettes and estimate health state utility values for late-onset Pompe disease in the United Kingdom.

  Abstract